These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gastroesophageal reflux disease. Control of symptoms, prevention of complications. Kaynard A; Flora K Postgrad Med; 2001 Sep; 110(3):42-4, 47-8, 51-3. PubMed ID: 11570205 [TBL] [Abstract][Full Text] [Related]
6. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Yadlapati R; Gyawali CP; Pandolfino JE; Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084 [TBL] [Abstract][Full Text] [Related]
9. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease. Lambert R Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472 [TBL] [Abstract][Full Text] [Related]
18. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS? Azzam RS Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291 [TBL] [Abstract][Full Text] [Related]
19. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. Hassall E J Pediatr; 2005 Mar; 146(3 Suppl):S3-12. PubMed ID: 15758900 [TBL] [Abstract][Full Text] [Related]